Amersin Life Sciences Corporation (HBEIE.OB) Subsidiary Expects 25% Increase In Revenue And Net Income For Fourth Quarter
10/19/2005 5:12:57 PM
More...
|
Amersin Life Sciences Corporation (HBEIE.OB) Subsidiary Receives New Contract For 1.5 Million Ribavirin Injections
10/19/2005 5:12:39 PM
More...
|
Amersin Life Sciences Corporation (HBEIE.OB) Announces 30% Increase In Ribavirin Production To Meet Market Demand Following Recent Avian Flu Outbreaks In Asia
10/19/2005 5:12:35 PM
More...
|
Amersin Life Sciences Corporation (HBEIE.OB) Announces Contract With China's International Tsunami Relief Program
10/19/2005 5:12:32 PM
More...
|
Hubei Pharmaceutical Group, Ltd. (HBEI.OB) Reports Third Quarter Operational Profit Of $635,981
10/19/2005 5:12:27 PM
More...
|
Amersin Life Sciences Corporation (HBEIE.OB) Announces New Trading Symbol And Completion Of Name Change
10/19/2005 5:12:24 PM
More...
|
Hubei Pharmaceutical Group, Ltd. (HBEI.OB) Announces Product Approval Process To Be Fast-Tracked By China's Food And Drug Agency
10/19/2005 5:12:20 PM
More...
|
Hubei Pharmaceutical Group, Ltd.'s (HBEI.OB) Xuejing(R) Makes Inroads Into China's Lucrative Haemostatic Products Market
10/19/2005 5:12:17 PM
More...
|
Hubei Pharmaceutical Group, Ltd. (HBEI.OB) Expands Through Acquisition Of New Joint Venture Interest
10/19/2005 5:11:36 PM
More...
|
Hubei Pharmaceutical Group, Ltd. (HBEI.OB) Announces Release Of New Contraceptive
10/19/2005 5:11:16 PM
More...
|
|